Improving patient care is the ultimate goal of any oncology-focused practice or facility. However, empowering staff to focus almost exclusively on patient care is far easier said than done. Post-pandemic staff is suffering from the highest rates of burn-out in history, with over 55% of front-line healthcare workers reporting mental and physical exhaustion. 62% of healthcare staff have also reported mental health repercussions which can lead to decreased presenteeism at work.
Canopy, the first Intelligent Care Platform for oncology, today announced results from a seventeen-month, real-world study of their ePRO-based patient monitoring platform. The single-site study of 923 patients at Highlands Oncology Group demonstrates the Canopy platform can be effectively implemented at a large scale with a high level of long-term patient enrollment, engagement, and retention. The study also found that the vast majority of patient issues were effectively resolved by nurse specialists and physician intervention was infrequently required.
Oncologists and oncology providers want the best for their patients, recognizing that being diagnosed with cancer is devastating, treatment is hard, and bad things can happen despite best efforts. They also understand patient expectations, doing everything possible to deliver an easier journey, the highest quality of life, and the best outcomes. Innovation is expected in oncology, with physicians and providers driving support for clinical trials and new treatment options, including the advancement of health technologies. As a result, we are now at a point where the evolution of the care delivery model, including the use of remote patient monitoring via electronic patient-reported outcomes (ePROs), needs to occur.
Are you currently evaluating the Enhancing Oncology Model (EOM) or other value-aligned payment programs? Canopy hosted a virtual panel discussion on strategies for the EOM and outcome-based care delivery, featuring thought leaders in community oncology:
Canopy, the first Intelligent Care Platform for oncology, today announced they will be presenting their research on the patient impact of their ePRO-based patient monitoring platform at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting, to be held June 3-7.
Canopy, the Intelligent Care Platform (ICP) for oncology, today announced it has raised$13 million in funding led by GSR Ventures, with participation from Samsung Next, UpWest, and other industry leaders and executives, such as Geoff Calkins (former SVP Product, Flatiron Health), and Chris Mansi (CEO Of Viz.AI). Formerly known as Expain, Canopy is also launching out of stealth today to make its platform generally available to cancer treatment centers across the U.S.
